Dose modification of alemtuzumab in combination with dexamethasone, cytarabine, and cisplatin in patients with relapsed or refractory peripheral T-cell lymphoma: analysis of efficacy and toxicity.

■ volume(issue):page = 이펍

■ 게재지명(논문명) = Investigational new drugs.

■ 저자 = Kim SJ, Kim K, Park Y, Kim BS, Huh J, Ko YH, Park K, Suh C, Kim WS.

■ 책임저자 = 김원석